Pfizer announces data presentations for investigational compounds in its lung cancer portfolio
29 June 2011 | By Pfizer
Pfizer Inc. will present early and mid-stage data from its lung cancer portfolio...
List view / Grid view
News
AstraZeneca and PTC announce strategic oncology drug discovery collaboration
29 June 2011 | By AstraZeneca
AstraZeneca & PTC have entered into an exclusive research collaboration & license agreement...
Tecan launches Tecan Award 2011
29 June 2011 | By kdm communications limited
Tecan announced that entries are now open for the 2011 Tecan Award. The Tecan Award is designed to celebrate the innovation and ingenuity of Tecan’s loyal customers...
Macmillan responds to NICE’s decision not to recommend lung cancer drug
29 June 2011 | By Macmillan Cancer Support
Mike Hobday, Head of Policy at Macmillan Cancer Support, said...
Pfizer files with the FDA for review of Axitinib for patients with advanced RCC
28 June 2011 | By Pfizer
The U.S. FDA has accepted Pfizer’s filing for standard review of axitinib for patients with advanced RCC...
UPS and Merck expand their distribution and logistics agreement
28 June 2011 | By Merck
UPS and Merck, announced that the companies have significantly broadened their existing distribution and logistics agreement...
GSK welcomes external scientists to diseases of the developing world research campus
28 June 2011 | By GlaxoSmithKline
External researchers have begun work in the GlaxoSmithKline ‘open lab’ in Spain...
Gilead Sciences announces agreement with Tibotec Pharmaceuticals
28 June 2011 | By Gilead Sciences, Inc.
Development and commercialization of a new fixed-dose antiretroviral combination product...
Thermo Fisher Scientific announces breakthrough workflow for metabolomics research
Thermo Fisher Scientific Inc., the world leader in serving science, today announced a breakthrough workflow to overcome key analytical and informatics challenges in metabolomics.
Investigational ultra-long-acting insulin degludec reduces hypoglycaemia
27 June 2011 | By Novo Nordisk
Ultra-long-acting insulin degludec, lowers blood glucose levels with significantly reduced rates of hypoglycaemia (low blood sugar)...
Sanofi appoints Peter Guenter, Senior Vice President, Europe
27 June 2011 | By Sanofi
Sanofi announced the appointment of Peter Guenter, as Senior Vice President, Europe, effective July 15, 2011...
Investigational compound DAPAGLIFLOZIN sustained glycemic control and weight reduction
27 June 2011 | By AstraZeneca
Results from an exploratory 78-week study...
Amgen submits application to expand indication for XGEVA® (Denosumab)
27 June 2011 | By Amgen
Amgen announced the submission of a supplemental Biologics License Application to the U.S. FDA to expand the indication for XGEVA® (denosumab)...
Sanofi Patient Group Bursary winners announced
27 June 2011 | By Sanofi
Sanofi announced the winners of the Sanofi Patient Group Bursary scheme - Breakthrough Breast Cancer and the MS Trust...
Wyatt Technology MALS Fulfils Latest European Pharmacopoeia Standard for HES Characterization
24 June 2011 | By The Scott Partnership
MALS instruments represent the latest EP requirements for HES characterization....
